nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—L-Tyrosine—Melphalan—ovarian cancer	0.487	1	CrCrCtD
Acetaminophen—ABCB1—ovarian cancer	0.131	1	CbGaD
Acetaminophen—ABCB1—Topotecan—ovarian cancer	0.0189	0.15	CbGbCtD
Acetaminophen—CYP2C8—Paclitaxel—ovarian cancer	0.0139	0.11	CbGbCtD
Acetaminophen—ABCB1—Vinorelbine—ovarian cancer	0.0133	0.106	CbGbCtD
Acetaminophen—CYP2D6—Vinorelbine—ovarian cancer	0.0126	0.0995	CbGbCtD
Acetaminophen—CYP3A4—Topotecan—ovarian cancer	0.0114	0.0898	CbGbCtD
Acetaminophen—CYP2C9—Paclitaxel—ovarian cancer	0.00966	0.0764	CbGbCtD
Acetaminophen—ABCB1—Paclitaxel—ovarian cancer	0.00938	0.0742	CbGbCtD
Acetaminophen—CYP3A4—Vinorelbine—ovarian cancer	0.008	0.0633	CbGbCtD
Acetaminophen—ABCB1—Docetaxel—ovarian cancer	0.00678	0.0536	CbGbCtD
Acetaminophen—CYP3A4—Paclitaxel—ovarian cancer	0.00562	0.0444	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—ovarian cancer	0.00505	0.04	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—ovarian cancer	0.00476	0.0377	CbGbCtD
Acetaminophen—CYP3A4—Docetaxel—ovarian cancer	0.00406	0.0321	CbGbCtD
Acetaminophen—PTGS2—ovarian follicle—ovarian cancer	0.00329	0.0591	CbGeAlD
Acetaminophen—CYP3A4—Doxorubicin—ovarian cancer	0.00303	0.024	CbGbCtD
Acetaminophen—SULT2A1—gonad—ovarian cancer	0.00207	0.0372	CbGeAlD
Acetaminophen—CNR1—decidua—ovarian cancer	0.00203	0.0365	CbGeAlD
Acetaminophen—SULT1E1—gonad—ovarian cancer	0.00191	0.0343	CbGeAlD
Acetaminophen—SULT2A1—female reproductive system—ovarian cancer	0.00185	0.0332	CbGeAlD
Acetaminophen—TRPV1—epithelium—ovarian cancer	0.00174	0.0313	CbGeAlD
Acetaminophen—SULT1E1—female reproductive system—ovarian cancer	0.0017	0.0306	CbGeAlD
Acetaminophen—SULT2A1—female gonad—ovarian cancer	0.00168	0.0302	CbGeAlD
Acetaminophen—UGT1A6—testis—ovarian cancer	0.0016	0.0288	CbGeAlD
Acetaminophen—SULT1E1—female gonad—ovarian cancer	0.00155	0.0279	CbGeAlD
Acetaminophen—SULT1E1—vagina—ovarian cancer	0.00154	0.0277	CbGeAlD
Acetaminophen—PTGS1—oviduct—ovarian cancer	0.00151	0.0272	CbGeAlD
Acetaminophen—SULT2A1—testis—ovarian cancer	0.00149	0.0268	CbGeAlD
Acetaminophen—SULT1A1—female reproductive system—ovarian cancer	0.00147	0.0264	CbGeAlD
Acetaminophen—TRPV1—gonad—ovarian cancer	0.00145	0.026	CbGeAlD
Acetaminophen—UGT2B15—female reproductive system—ovarian cancer	0.00141	0.0255	CbGeAlD
Acetaminophen—SULT1E1—testis—ovarian cancer	0.00137	0.0247	CbGeAlD
Acetaminophen—SULT1A1—female gonad—ovarian cancer	0.00133	0.024	CbGeAlD
Acetaminophen—SULT1A1—vagina—ovarian cancer	0.00133	0.0239	CbGeAlD
Acetaminophen—TRPV1—female reproductive system—ovarian cancer	0.00129	0.0232	CbGeAlD
Acetaminophen—CNR1—testis—ovarian cancer	0.00129	0.0231	CbGeAlD
Acetaminophen—SULT1A1—testis—ovarian cancer	0.00118	0.0213	CbGeAlD
Acetaminophen—SULT2A1—lymph node—ovarian cancer	0.00108	0.0194	CbGeAlD
Acetaminophen—TRPV1—testis—ovarian cancer	0.00104	0.0187	CbGeAlD
Acetaminophen—SULT1E1—lymph node—ovarian cancer	0.000997	0.0179	CbGeAlD
Acetaminophen—CNR1—lymph node—ovarian cancer	0.000932	0.0168	CbGeAlD
Acetaminophen—SULT1A1—lymph node—ovarian cancer	0.000858	0.0154	CbGeAlD
Acetaminophen—CYP2A6—vagina—ovarian cancer	0.00056	0.0101	CbGeAlD
Acetaminophen—PTGS2—myometrium—ovarian cancer	0.000462	0.00832	CbGeAlD
Acetaminophen—PTGS2—embryo—ovarian cancer	0.000445	0.008	CbGeAlD
Acetaminophen—CYP1A1—epithelium—ovarian cancer	0.000432	0.00777	CbGeAlD
Acetaminophen—CYP1A1—uterine cervix—ovarian cancer	0.000428	0.00771	CbGeAlD
Acetaminophen—CYP2C8—endometrium—ovarian cancer	0.00042	0.00755	CbGeAlD
Acetaminophen—PTGS1—epithelium—ovarian cancer	0.00038	0.00683	CbGeAlD
Acetaminophen—PTGS1—uterine cervix—ovarian cancer	0.000376	0.00677	CbGeAlD
Acetaminophen—PTGS2—epithelium—ovarian cancer	0.000363	0.00653	CbGeAlD
Acetaminophen—PTGS2—uterine cervix—ovarian cancer	0.00036	0.00647	CbGeAlD
Acetaminophen—CYP1A1—uterus—ovarian cancer	0.000357	0.00642	CbGeAlD
Acetaminophen—CYP2C8—female reproductive system—ovarian cancer	0.000348	0.00626	CbGeAlD
Acetaminophen—PTGS1—endometrium—ovarian cancer	0.00034	0.00612	CbGeAlD
Acetaminophen—PTGS2—endometrium—ovarian cancer	0.000325	0.00585	CbGeAlD
Acetaminophen—CYP1A1—female reproductive system—ovarian cancer	0.000321	0.00577	CbGeAlD
Acetaminophen—CYP2C8—vagina—ovarian cancer	0.000314	0.00566	CbGeAlD
Acetaminophen—PTGS1—uterus—ovarian cancer	0.000314	0.00564	CbGeAlD
Acetaminophen—CYP2C9—female reproductive system—ovarian cancer	0.000309	0.00556	CbGeAlD
Acetaminophen—PTGS2—uterus—ovarian cancer	0.0003	0.00539	CbGeAlD
Acetaminophen—CYP2E1—female reproductive system—ovarian cancer	0.000293	0.00527	CbGeAlD
Acetaminophen—CYP1A1—female gonad—ovarian cancer	0.000292	0.00525	CbGeAlD
Acetaminophen—CYP1A1—vagina—ovarian cancer	0.00029	0.00522	CbGeAlD
Acetaminophen—ABCB1—myometrium—ovarian cancer	0.000286	0.00514	CbGeAlD
Acetaminophen—PTGS1—female reproductive system—ovarian cancer	0.000282	0.00507	CbGeAlD
Acetaminophen—CYP2C8—testis—ovarian cancer	0.000281	0.00505	CbGeAlD
Acetaminophen—ABCB1—embryo—ovarian cancer	0.000275	0.00495	CbGeAlD
Acetaminophen—PTGS2—female reproductive system—ovarian cancer	0.000269	0.00485	CbGeAlD
Acetaminophen—PTGS1—female gonad—ovarian cancer	0.000257	0.00462	CbGeAlD
Acetaminophen—PTGS1—vagina—ovarian cancer	0.000255	0.00459	CbGeAlD
Acetaminophen—PTGS2—bone marrow—ovarian cancer	0.000254	0.00458	CbGeAlD
Acetaminophen—PTGS2—female gonad—ovarian cancer	0.000245	0.00441	CbGeAlD
Acetaminophen—PTGS2—vagina—ovarian cancer	0.000244	0.00438	CbGeAlD
Acetaminophen—CYP2E1—testis—ovarian cancer	0.000236	0.00425	CbGeAlD
Acetaminophen—CYP3A4—female reproductive system—ovarian cancer	0.000235	0.00424	CbGeAlD
Acetaminophen—CYP2D6—female reproductive system—ovarian cancer	0.000232	0.00417	CbGeAlD
Acetaminophen—PTGS1—testis—ovarian cancer	0.000228	0.00409	CbGeAlD
Acetaminophen—ABCB1—epithelium—ovarian cancer	0.000224	0.00404	CbGeAlD
Acetaminophen—ABCB1—uterine cervix—ovarian cancer	0.000222	0.004	CbGeAlD
Acetaminophen—ABCB1—decidua—ovarian cancer	0.000212	0.00381	CbGeAlD
Acetaminophen—CYP2D6—female gonad—ovarian cancer	0.000211	0.00379	CbGeAlD
Acetaminophen—ABCB1—endometrium—ovarian cancer	0.000201	0.00362	CbGeAlD
Acetaminophen—CYP1A1—lymph node—ovarian cancer	0.000188	0.00338	CbGeAlD
Acetaminophen—CYP2D6—testis—ovarian cancer	0.000187	0.00336	CbGeAlD
Acetaminophen—ABCB1—gonad—ovarian cancer	0.000187	0.00336	CbGeAlD
Acetaminophen—ABCB1—uterus—ovarian cancer	0.000185	0.00334	CbGeAlD
Acetaminophen—ABCB1—female reproductive system—ovarian cancer	0.000167	0.003	CbGeAlD
Acetaminophen—PTGS1—lymph node—ovarian cancer	0.000165	0.00297	CbGeAlD
Acetaminophen—PTGS2—lymph node—ovarian cancer	0.000158	0.00284	CbGeAlD
Acetaminophen—ABCB1—bone marrow—ovarian cancer	0.000157	0.00283	CbGeAlD
Acetaminophen—ABCB1—female gonad—ovarian cancer	0.000152	0.00273	CbGeAlD
Acetaminophen—ABCB1—vagina—ovarian cancer	0.000151	0.00271	CbGeAlD
Acetaminophen—ABCB1—testis—ovarian cancer	0.000135	0.00242	CbGeAlD
Acetaminophen—Nausea—Melphalan—ovarian cancer	0.000128	0.000984	CcSEcCtD
Acetaminophen—Confusional state—Paclitaxel—ovarian cancer	0.000128	0.000981	CcSEcCtD
Acetaminophen—Asthma—Epirubicin—ovarian cancer	0.000127	0.000978	CcSEcCtD
Acetaminophen—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000127	0.000973	CcSEcCtD
Acetaminophen—Oedema—Paclitaxel—ovarian cancer	0.000127	0.000973	CcSEcCtD
Acetaminophen—Muscle spasms—Docetaxel—ovarian cancer	0.000126	0.000972	CcSEcCtD
Acetaminophen—Shock—Paclitaxel—ovarian cancer	0.000125	0.000957	CcSEcCtD
Acetaminophen—Dizziness—Vinorelbine—ovarian cancer	0.000124	0.000957	CcSEcCtD
Acetaminophen—Nervous system disorder—Paclitaxel—ovarian cancer	0.000124	0.000954	CcSEcCtD
Acetaminophen—Hypokalaemia—Doxorubicin—ovarian cancer	0.000124	0.000953	CcSEcCtD
Acetaminophen—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000124	0.000953	CcSEcCtD
Acetaminophen—Tachycardia—Paclitaxel—ovarian cancer	0.000124	0.00095	CcSEcCtD
Acetaminophen—Skin disorder—Paclitaxel—ovarian cancer	0.000123	0.000945	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000123	0.000943	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000123	0.000943	CcSEcCtD
Acetaminophen—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000122	0.000941	CcSEcCtD
Acetaminophen—Anaemia—Docetaxel—ovarian cancer	0.000122	0.000934	CcSEcCtD
Acetaminophen—Pancytopenia—Epirubicin—ovarian cancer	0.000121	0.000929	CcSEcCtD
Acetaminophen—Anorexia—Paclitaxel—ovarian cancer	0.000121	0.000928	CcSEcCtD
Acetaminophen—Muscular weakness—Doxorubicin—ovarian cancer	0.00012	0.000924	CcSEcCtD
Acetaminophen—Vomiting—Vinorelbine—ovarian cancer	0.00012	0.00092	CcSEcCtD
Acetaminophen—Dysuria—Epirubicin—ovarian cancer	0.000119	0.000915	CcSEcCtD
Acetaminophen—Neutropenia—Epirubicin—ovarian cancer	0.000119	0.000915	CcSEcCtD
Acetaminophen—Rash—Vinorelbine—ovarian cancer	0.000119	0.000912	CcSEcCtD
Acetaminophen—Dermatitis—Vinorelbine—ovarian cancer	0.000119	0.000911	CcSEcCtD
Acetaminophen—Abdominal distension—Doxorubicin—ovarian cancer	0.000119	0.000911	CcSEcCtD
Acetaminophen—Hypotension—Paclitaxel—ovarian cancer	0.000118	0.000909	CcSEcCtD
Acetaminophen—Headache—Vinorelbine—ovarian cancer	0.000118	0.000906	CcSEcCtD
Acetaminophen—Asthma—Doxorubicin—ovarian cancer	0.000118	0.000905	CcSEcCtD
Acetaminophen—Leukopenia—Docetaxel—ovarian cancer	0.000118	0.000905	CcSEcCtD
Acetaminophen—Palpitations—Docetaxel—ovarian cancer	0.000116	0.000893	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000116	0.000893	CcSEcCtD
Acetaminophen—Hyperglycaemia—Epirubicin—ovarian cancer	0.000115	0.000882	CcSEcCtD
Acetaminophen—Cough—Docetaxel—ovarian cancer	0.000115	0.000882	CcSEcCtD
Acetaminophen—Insomnia—Paclitaxel—ovarian cancer	0.000115	0.00088	CcSEcCtD
Acetaminophen—Convulsion—Docetaxel—ovarian cancer	0.000114	0.000876	CcSEcCtD
Acetaminophen—Hypertension—Docetaxel—ovarian cancer	0.000114	0.000872	CcSEcCtD
Acetaminophen—Drowsiness—Epirubicin—ovarian cancer	0.000114	0.000872	CcSEcCtD
Acetaminophen—Dyspnoea—Paclitaxel—ovarian cancer	0.000113	0.000868	CcSEcCtD
Acetaminophen—Somnolence—Paclitaxel—ovarian cancer	0.000113	0.000865	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000113	0.000865	CcSEcCtD
Acetaminophen—Chest pain—Docetaxel—ovarian cancer	0.000112	0.00086	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—ovarian cancer	0.000112	0.00086	CcSEcCtD
Acetaminophen—Nausea—Vinorelbine—ovarian cancer	0.000112	0.000859	CcSEcCtD
Acetaminophen—Dyspepsia—Paclitaxel—ovarian cancer	0.000111	0.000857	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000111	0.000854	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—ovarian cancer	0.00011	0.000846	CcSEcCtD
Acetaminophen—Neutropenia—Doxorubicin—ovarian cancer	0.00011	0.000846	CcSEcCtD
Acetaminophen—Decreased appetite—Paclitaxel—ovarian cancer	0.00011	0.000846	CcSEcCtD
Acetaminophen—Dry mouth—Docetaxel—ovarian cancer	0.000109	0.000841	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000109	0.00084	CcSEcCtD
Acetaminophen—Fatigue—Paclitaxel—ovarian cancer	0.000109	0.000839	CcSEcCtD
Acetaminophen—Sweating—Epirubicin—ovarian cancer	0.000109	0.000836	CcSEcCtD
Acetaminophen—Constipation—Paclitaxel—ovarian cancer	0.000108	0.000832	CcSEcCtD
Acetaminophen—Confusional state—Docetaxel—ovarian cancer	0.000108	0.000832	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000108	0.000826	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000107	0.000825	CcSEcCtD
Acetaminophen—Anaphylactic shock—Docetaxel—ovarian cancer	0.000107	0.000825	CcSEcCtD
Acetaminophen—Oedema—Docetaxel—ovarian cancer	0.000107	0.000825	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000106	0.000817	CcSEcCtD
Acetaminophen—Agranulocytosis—Epirubicin—ovarian cancer	0.000106	0.000814	CcSEcCtD
Acetaminophen—Shock—Docetaxel—ovarian cancer	0.000106	0.000811	CcSEcCtD
Acetaminophen—Nervous system disorder—Docetaxel—ovarian cancer	0.000105	0.000809	CcSEcCtD
Acetaminophen—Thrombocytopenia—Docetaxel—ovarian cancer	0.000105	0.000808	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—ovarian cancer	0.000105	0.000807	CcSEcCtD
Acetaminophen—Tachycardia—Docetaxel—ovarian cancer	0.000105	0.000805	CcSEcCtD
Acetaminophen—Feeling abnormal—Paclitaxel—ovarian cancer	0.000104	0.000802	CcSEcCtD
Acetaminophen—Skin disorder—Docetaxel—ovarian cancer	0.000104	0.000801	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000104	0.0008	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000104	0.000796	CcSEcCtD
Acetaminophen—Haemoglobin—Epirubicin—ovarian cancer	0.000102	0.000787	CcSEcCtD
Acetaminophen—Anorexia—Docetaxel—ovarian cancer	0.000102	0.000786	CcSEcCtD
Acetaminophen—Haemorrhage—Epirubicin—ovarian cancer	0.000102	0.000783	CcSEcCtD
Acetaminophen—Hepatitis—Epirubicin—ovarian cancer	0.000102	0.000783	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—ovarian cancer	0.000101	0.000774	CcSEcCtD
Acetaminophen—Urinary tract disorder—Epirubicin—ovarian cancer	0.000101	0.000773	CcSEcCtD
Acetaminophen—Urticaria—Paclitaxel—ovarian cancer	0.000101	0.000773	CcSEcCtD
Acetaminophen—Oedema peripheral—Epirubicin—ovarian cancer	0.0001	0.000771	CcSEcCtD
Acetaminophen—Hypotension—Docetaxel—ovarian cancer	0.0001	0.000771	CcSEcCtD
Acetaminophen—Connective tissue disorder—Epirubicin—ovarian cancer	0.0001	0.000769	CcSEcCtD
Acetaminophen—Abdominal pain—Paclitaxel—ovarian cancer	0.0001	0.000769	CcSEcCtD
Acetaminophen—Body temperature increased—Paclitaxel—ovarian cancer	0.0001	0.000769	CcSEcCtD
Acetaminophen—Urethral disorder—Epirubicin—ovarian cancer	9.99e-05	0.000768	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—ovarian cancer	9.93e-05	0.000763	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—ovarian cancer	9.8e-05	0.000753	CcSEcCtD
Acetaminophen—ABCB1—lymph node—ovarian cancer	9.75e-05	0.00175	CbGeAlD
Acetaminophen—Insomnia—Docetaxel—ovarian cancer	9.71e-05	0.000746	CcSEcCtD
Acetaminophen—Erythema multiforme—Epirubicin—ovarian cancer	9.63e-05	0.00074	CcSEcCtD
Acetaminophen—Dyspnoea—Docetaxel—ovarian cancer	9.57e-05	0.000735	CcSEcCtD
Acetaminophen—Somnolence—Docetaxel—ovarian cancer	9.54e-05	0.000733	CcSEcCtD
Acetaminophen—Eye disorder—Epirubicin—ovarian cancer	9.52e-05	0.000732	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—ovarian cancer	9.48e-05	0.000728	CcSEcCtD
Acetaminophen—Flushing—Epirubicin—ovarian cancer	9.46e-05	0.000727	CcSEcCtD
Acetaminophen—Cardiac disorder—Epirubicin—ovarian cancer	9.46e-05	0.000727	CcSEcCtD
Acetaminophen—Dyspepsia—Docetaxel—ovarian cancer	9.45e-05	0.000726	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—ovarian cancer	9.43e-05	0.000725	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—ovarian cancer	9.43e-05	0.000725	CcSEcCtD
Acetaminophen—Decreased appetite—Docetaxel—ovarian cancer	9.33e-05	0.000717	CcSEcCtD
Acetaminophen—Hypersensitivity—Paclitaxel—ovarian cancer	9.33e-05	0.000717	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—ovarian cancer	9.31e-05	0.000715	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—ovarian cancer	9.29e-05	0.000714	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.27e-05	0.000712	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—ovarian cancer	9.26e-05	0.000712	CcSEcCtD
Acetaminophen—Fatigue—Docetaxel—ovarian cancer	9.25e-05	0.000711	CcSEcCtD
Acetaminophen—Angiopathy—Epirubicin—ovarian cancer	9.24e-05	0.00071	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—ovarian cancer	9.24e-05	0.00071	CcSEcCtD
Acetaminophen—Immune system disorder—Epirubicin—ovarian cancer	9.2e-05	0.000707	CcSEcCtD
Acetaminophen—Mediastinal disorder—Epirubicin—ovarian cancer	9.18e-05	0.000706	CcSEcCtD
Acetaminophen—Constipation—Docetaxel—ovarian cancer	9.18e-05	0.000705	CcSEcCtD
Acetaminophen—Chills—Epirubicin—ovarian cancer	9.14e-05	0.000703	CcSEcCtD
Acetaminophen—Asthenia—Paclitaxel—ovarian cancer	9.09e-05	0.000698	CcSEcCtD
Acetaminophen—Pruritus—Paclitaxel—ovarian cancer	8.96e-05	0.000688	CcSEcCtD
Acetaminophen—Mental disorder—Epirubicin—ovarian cancer	8.93e-05	0.000686	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—ovarian cancer	8.91e-05	0.000685	CcSEcCtD
Acetaminophen—Malnutrition—Epirubicin—ovarian cancer	8.87e-05	0.000682	CcSEcCtD
Acetaminophen—Erythema—Epirubicin—ovarian cancer	8.87e-05	0.000682	CcSEcCtD
Acetaminophen—Feeling abnormal—Docetaxel—ovarian cancer	8.84e-05	0.00068	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—ovarian cancer	8.81e-05	0.000677	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Docetaxel—ovarian cancer	8.78e-05	0.000674	CcSEcCtD
Acetaminophen—Cardiac disorder—Doxorubicin—ovarian cancer	8.75e-05	0.000672	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—ovarian cancer	8.75e-05	0.000672	CcSEcCtD
Acetaminophen—Tension—Epirubicin—ovarian cancer	8.7e-05	0.000669	CcSEcCtD
Acetaminophen—Diarrhoea—Paclitaxel—ovarian cancer	8.66e-05	0.000666	CcSEcCtD
Acetaminophen—Nervousness—Epirubicin—ovarian cancer	8.62e-05	0.000662	CcSEcCtD
Acetaminophen—Angiopathy—Doxorubicin—ovarian cancer	8.55e-05	0.000657	CcSEcCtD
Acetaminophen—Muscle spasms—Epirubicin—ovarian cancer	8.53e-05	0.000655	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—ovarian cancer	8.52e-05	0.000654	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—ovarian cancer	8.5e-05	0.000653	CcSEcCtD
Acetaminophen—Body temperature increased—Docetaxel—ovarian cancer	8.48e-05	0.000652	CcSEcCtD
Acetaminophen—Abdominal pain—Docetaxel—ovarian cancer	8.48e-05	0.000652	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—ovarian cancer	8.46e-05	0.00065	CcSEcCtD
Acetaminophen—Dizziness—Paclitaxel—ovarian cancer	8.37e-05	0.000643	CcSEcCtD
Acetaminophen—Vision blurred—Epirubicin—ovarian cancer	8.36e-05	0.000642	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—ovarian cancer	8.26e-05	0.000635	CcSEcCtD
Acetaminophen—Ill-defined disorder—Epirubicin—ovarian cancer	8.23e-05	0.000632	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—ovarian cancer	8.21e-05	0.000631	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—ovarian cancer	8.21e-05	0.000631	CcSEcCtD
Acetaminophen—Anaemia—Epirubicin—ovarian cancer	8.2e-05	0.00063	CcSEcCtD
Acetaminophen—Agitation—Epirubicin—ovarian cancer	8.15e-05	0.000626	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—ovarian cancer	8.05e-05	0.000619	CcSEcCtD
Acetaminophen—Vomiting—Paclitaxel—ovarian cancer	8.05e-05	0.000619	CcSEcCtD
Acetaminophen—Malaise—Epirubicin—ovarian cancer	8e-05	0.000615	CcSEcCtD
Acetaminophen—Rash—Paclitaxel—ovarian cancer	7.98e-05	0.000614	CcSEcCtD
Acetaminophen—Dermatitis—Paclitaxel—ovarian cancer	7.98e-05	0.000613	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—ovarian cancer	7.97e-05	0.000613	CcSEcCtD
Acetaminophen—Leukopenia—Epirubicin—ovarian cancer	7.94e-05	0.00061	CcSEcCtD
Acetaminophen—Headache—Paclitaxel—ovarian cancer	7.93e-05	0.00061	CcSEcCtD
Acetaminophen—Hypersensitivity—Docetaxel—ovarian cancer	7.91e-05	0.000608	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—ovarian cancer	7.89e-05	0.000606	CcSEcCtD
Acetaminophen—Palpitations—Epirubicin—ovarian cancer	7.84e-05	0.000602	CcSEcCtD
Acetaminophen—Cough—Epirubicin—ovarian cancer	7.74e-05	0.000595	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—ovarian cancer	7.73e-05	0.000594	CcSEcCtD
Acetaminophen—Asthenia—Docetaxel—ovarian cancer	7.7e-05	0.000592	CcSEcCtD
Acetaminophen—Convulsion—Epirubicin—ovarian cancer	7.69e-05	0.000591	CcSEcCtD
Acetaminophen—Hypertension—Epirubicin—ovarian cancer	7.66e-05	0.000588	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—ovarian cancer	7.62e-05	0.000585	CcSEcCtD
Acetaminophen—Pruritus—Docetaxel—ovarian cancer	7.59e-05	0.000584	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—ovarian cancer	7.59e-05	0.000583	CcSEcCtD
Acetaminophen—Chest pain—Epirubicin—ovarian cancer	7.55e-05	0.00058	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—ovarian cancer	7.54e-05	0.00058	CcSEcCtD
Acetaminophen—Anxiety—Epirubicin—ovarian cancer	7.53e-05	0.000578	CcSEcCtD
Acetaminophen—Nausea—Paclitaxel—ovarian cancer	7.52e-05	0.000578	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	7.5e-05	0.000576	CcSEcCtD
Acetaminophen—Discomfort—Epirubicin—ovarian cancer	7.46e-05	0.000573	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—ovarian cancer	7.4e-05	0.000569	CcSEcCtD
Acetaminophen—Dry mouth—Epirubicin—ovarian cancer	7.39e-05	0.000568	CcSEcCtD
Acetaminophen—Leukopenia—Doxorubicin—ovarian cancer	7.35e-05	0.000565	CcSEcCtD
Acetaminophen—Diarrhoea—Docetaxel—ovarian cancer	7.34e-05	0.000564	CcSEcCtD
Acetaminophen—Confusional state—Epirubicin—ovarian cancer	7.3e-05	0.000561	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—ovarian cancer	7.25e-05	0.000557	CcSEcCtD
Acetaminophen—Anaphylactic shock—Epirubicin—ovarian cancer	7.24e-05	0.000556	CcSEcCtD
Acetaminophen—Oedema—Epirubicin—ovarian cancer	7.24e-05	0.000556	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—ovarian cancer	7.16e-05	0.00055	CcSEcCtD
Acetaminophen—Shock—Epirubicin—ovarian cancer	7.12e-05	0.000547	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—ovarian cancer	7.11e-05	0.000546	CcSEcCtD
Acetaminophen—Nervous system disorder—Epirubicin—ovarian cancer	7.1e-05	0.000546	CcSEcCtD
Acetaminophen—Dizziness—Docetaxel—ovarian cancer	7.1e-05	0.000545	CcSEcCtD
Acetaminophen—Thrombocytopenia—Epirubicin—ovarian cancer	7.09e-05	0.000545	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—ovarian cancer	7.09e-05	0.000545	CcSEcCtD
Acetaminophen—Tachycardia—Epirubicin—ovarian cancer	7.07e-05	0.000543	CcSEcCtD
Acetaminophen—Skin disorder—Epirubicin—ovarian cancer	7.03e-05	0.00054	CcSEcCtD
Acetaminophen—Hyperhidrosis—Epirubicin—ovarian cancer	7e-05	0.000538	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—ovarian cancer	6.99e-05	0.000537	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—ovarian cancer	6.96e-05	0.000535	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	6.94e-05	0.000533	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—ovarian cancer	6.9e-05	0.000531	CcSEcCtD
Acetaminophen—Anorexia—Epirubicin—ovarian cancer	6.9e-05	0.00053	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—ovarian cancer	6.83e-05	0.000525	CcSEcCtD
Acetaminophen—Vomiting—Docetaxel—ovarian cancer	6.82e-05	0.000524	CcSEcCtD
Acetaminophen—Rash—Docetaxel—ovarian cancer	6.77e-05	0.00052	CcSEcCtD
Acetaminophen—Hypotension—Epirubicin—ovarian cancer	6.76e-05	0.00052	CcSEcCtD
Acetaminophen—Dermatitis—Docetaxel—ovarian cancer	6.76e-05	0.00052	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—ovarian cancer	6.75e-05	0.000519	CcSEcCtD
Acetaminophen—Headache—Docetaxel—ovarian cancer	6.72e-05	0.000517	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—ovarian cancer	6.7e-05	0.000515	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—ovarian cancer	6.7e-05	0.000515	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—ovarian cancer	6.59e-05	0.000506	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—ovarian cancer	6.57e-05	0.000505	CcSEcCtD
Acetaminophen—Thrombocytopenia—Doxorubicin—ovarian cancer	6.56e-05	0.000504	CcSEcCtD
Acetaminophen—Insomnia—Epirubicin—ovarian cancer	6.55e-05	0.000503	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—ovarian cancer	6.54e-05	0.000502	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—ovarian cancer	6.51e-05	0.0005	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—ovarian cancer	6.48e-05	0.000498	CcSEcCtD
Acetaminophen—Dyspnoea—Epirubicin—ovarian cancer	6.45e-05	0.000496	CcSEcCtD
Acetaminophen—Somnolence—Epirubicin—ovarian cancer	6.44e-05	0.000495	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—ovarian cancer	6.38e-05	0.000491	CcSEcCtD
Acetaminophen—Nausea—Docetaxel—ovarian cancer	6.38e-05	0.00049	CcSEcCtD
Acetaminophen—Dyspepsia—Epirubicin—ovarian cancer	6.37e-05	0.00049	CcSEcCtD
Acetaminophen—Decreased appetite—Epirubicin—ovarian cancer	6.29e-05	0.000484	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—ovarian cancer	6.26e-05	0.000481	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.25e-05	0.00048	CcSEcCtD
Acetaminophen—Fatigue—Epirubicin—ovarian cancer	6.24e-05	0.00048	CcSEcCtD
Acetaminophen—Constipation—Epirubicin—ovarian cancer	6.19e-05	0.000476	CcSEcCtD
Acetaminophen—Insomnia—Doxorubicin—ovarian cancer	6.06e-05	0.000466	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—ovarian cancer	5.97e-05	0.000459	CcSEcCtD
Acetaminophen—Feeling abnormal—Epirubicin—ovarian cancer	5.97e-05	0.000458	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—ovarian cancer	5.95e-05	0.000458	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Epirubicin—ovarian cancer	5.92e-05	0.000455	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—ovarian cancer	5.9e-05	0.000453	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—ovarian cancer	5.82e-05	0.000447	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.78e-05	0.000444	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—ovarian cancer	5.78e-05	0.000444	CcSEcCtD
Acetaminophen—Urticaria—Epirubicin—ovarian cancer	5.75e-05	0.000442	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—ovarian cancer	5.73e-05	0.00044	CcSEcCtD
Acetaminophen—Abdominal pain—Epirubicin—ovarian cancer	5.72e-05	0.00044	CcSEcCtD
Acetaminophen—Body temperature increased—Epirubicin—ovarian cancer	5.72e-05	0.00044	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—ovarian cancer	5.52e-05	0.000424	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.48e-05	0.000421	CcSEcCtD
Acetaminophen—Hypersensitivity—Epirubicin—ovarian cancer	5.33e-05	0.00041	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—ovarian cancer	5.32e-05	0.000409	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—ovarian cancer	5.3e-05	0.000407	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—ovarian cancer	5.3e-05	0.000407	CcSEcCtD
Acetaminophen—Asthenia—Epirubicin—ovarian cancer	5.19e-05	0.000399	CcSEcCtD
Acetaminophen—Pruritus—Epirubicin—ovarian cancer	5.12e-05	0.000394	CcSEcCtD
Acetaminophen—Diarrhoea—Epirubicin—ovarian cancer	4.95e-05	0.000381	CcSEcCtD
Acetaminophen—Hypersensitivity—Doxorubicin—ovarian cancer	4.94e-05	0.000379	CcSEcCtD
Acetaminophen—Asthenia—Doxorubicin—ovarian cancer	4.81e-05	0.000369	CcSEcCtD
Acetaminophen—Dizziness—Epirubicin—ovarian cancer	4.79e-05	0.000368	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—ovarian cancer	4.74e-05	0.000364	CcSEcCtD
Acetaminophen—Vomiting—Epirubicin—ovarian cancer	4.6e-05	0.000354	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—ovarian cancer	4.58e-05	0.000352	CcSEcCtD
Acetaminophen—Rash—Epirubicin—ovarian cancer	4.56e-05	0.000351	CcSEcCtD
Acetaminophen—Dermatitis—Epirubicin—ovarian cancer	4.56e-05	0.00035	CcSEcCtD
Acetaminophen—Headache—Epirubicin—ovarian cancer	4.54e-05	0.000349	CcSEcCtD
Acetaminophen—Dizziness—Doxorubicin—ovarian cancer	4.43e-05	0.00034	CcSEcCtD
Acetaminophen—Nausea—Epirubicin—ovarian cancer	4.3e-05	0.00033	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—ovarian cancer	4.26e-05	0.000327	CcSEcCtD
Acetaminophen—Rash—Doxorubicin—ovarian cancer	4.22e-05	0.000325	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—ovarian cancer	4.22e-05	0.000324	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—ovarian cancer	4.2e-05	0.000322	CcSEcCtD
Acetaminophen—Nausea—Doxorubicin—ovarian cancer	3.98e-05	0.000306	CcSEcCtD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	9.8e-06	0.00014	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	9.8e-06	0.00014	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—VEGFA—ovarian cancer	9.79e-06	0.00014	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—STAT3—ovarian cancer	9.7e-06	0.000139	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NRAS—ovarian cancer	9.67e-06	0.000138	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—YAP1—ovarian cancer	9.62e-06	0.000138	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CYP1B1—ovarian cancer	9.59e-06	0.000137	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	9.58e-06	0.000137	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.52e-06	0.000136	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.43e-06	0.000135	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PIK3CA—ovarian cancer	9.32e-06	0.000133	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MAPK3—ovarian cancer	9.26e-06	0.000132	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	9.26e-06	0.000132	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—BRIP1—ovarian cancer	9.15e-06	0.000131	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPP1CC—ovarian cancer	9.15e-06	0.000131	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MYC—ovarian cancer	9.01e-06	0.000129	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPP2R1A—ovarian cancer	8.99e-06	0.000129	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.95e-06	0.000128	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—FASN—ovarian cancer	8.84e-06	0.000126	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—YAP1—ovarian cancer	8.82e-06	0.000126	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MAPK1—ovarian cancer	8.81e-06	0.000126	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—EGFR—ovarian cancer	8.81e-06	0.000126	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	8.73e-06	0.000125	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SLC5A5—ovarian cancer	8.69e-06	0.000124	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PPP2R1A—ovarian cancer	8.52e-06	0.000122	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	8.51e-06	0.000122	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	8.5e-06	0.000122	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—AKT1—ovarian cancer	8.49e-06	0.000121	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SLC2A1—ovarian cancer	8.4e-06	0.00012	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.37e-06	0.00012	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ABCB1—ovarian cancer	8.35e-06	0.000119	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KRAS—ovarian cancer	8.32e-06	0.000119	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—FASN—ovarian cancer	8.32e-06	0.000119	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	8.23e-06	0.000118	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.22e-06	0.000117	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—TYMS—ovarian cancer	8.2e-06	0.000117	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SLC5A5—ovarian cancer	8.18e-06	0.000117	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CAV1—ovarian cancer	8.11e-06	0.000116	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CAV1—ovarian cancer	8.11e-06	0.000116	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AKT1—ovarian cancer	8.1e-06	0.000116	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYTB—ovarian cancer	8.08e-06	0.000115	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CYP1B1—ovarian cancer	8.05e-06	0.000115	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SLC2A1—ovarian cancer	7.9e-06	0.000113	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ABCB1—ovarian cancer	7.9e-06	0.000113	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—FASN—ovarian cancer	7.84e-06	0.000112	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	7.8e-06	0.000111	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PIK3CA—ovarian cancer	7.78e-06	0.000111	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—TYMS—ovarian cancer	7.75e-06	0.000111	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.74e-06	0.000111	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SLC5A5—ovarian cancer	7.72e-06	0.00011	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—YAP1—ovarian cancer	7.69e-06	0.00011	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	7.67e-06	0.00011	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PIK3CA—ovarian cancer	7.65e-06	0.000109	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AKT1—ovarian cancer	7.61e-06	0.000109	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CYP1B1—ovarian cancer	7.58e-06	0.000108	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SLC2A1—ovarian cancer	7.45e-06	0.000106	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—ovarian cancer	7.4e-06	0.000106	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CG—ovarian cancer	7.38e-06	0.000106	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CG—ovarian cancer	7.38e-06	0.000106	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.3e-06	0.000104	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—YAP1—ovarian cancer	7.24e-06	0.000103	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—FASN—ovarian cancer	7.19e-06	0.000103	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—YAP1—ovarian cancer	7.18e-06	0.000103	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CYP1B1—ovarian cancer	7.14e-06	0.000102	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPP2R1A—ovarian cancer	7.14e-06	0.000102	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.11e-06	0.000102	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.1e-06	0.000102	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HRAS—ovarian cancer	7.08e-06	0.000101	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.07e-06	0.000101	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.06e-06	0.000101	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.06e-06	0.000101	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	6.95e-06	9.93e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SLC2A1—ovarian cancer	6.83e-06	9.76e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL6—ovarian cancer	6.77e-06	9.68e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TERT—ovarian cancer	6.77e-06	9.68e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	6.72e-06	9.6e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.69e-06	9.56e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.67e-06	9.53e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ABCB1—ovarian cancer	6.63e-06	9.47e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CAV1—ovarian cancer	6.61e-06	9.44e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CYP1B1—ovarian cancer	6.55e-06	9.36e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—TYMS—ovarian cancer	6.51e-06	9.3e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CD—ovarian cancer	6.49e-06	9.28e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CD—ovarian cancer	6.49e-06	9.28e-05	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AKT1—ovarian cancer	6.35e-06	9.08e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	6.34e-06	9.05e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.31e-06	9.02e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.3e-06	9.01e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—FASN—ovarian cancer	6.26e-06	8.95e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CAV1—ovarian cancer	6.26e-06	8.95e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CAV1—ovarian cancer	6.25e-06	8.93e-05	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AKT1—ovarian cancer	6.25e-06	8.93e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.25e-06	8.93e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ABCB1—ovarian cancer	6.24e-06	8.92e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.16e-06	8.81e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—YAP1—ovarian cancer	6.14e-06	8.77e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—TYMS—ovarian cancer	6.13e-06	8.76e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	6.07e-06	8.68e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CG—ovarian cancer	6.02e-06	8.6e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SLC2A1—ovarian cancer	5.95e-06	8.51e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—IL6ST—ovarian cancer	5.94e-06	8.49e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—FASN—ovarian cancer	5.9e-06	8.44e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ABCB1—ovarian cancer	5.88e-06	8.41e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—FASN—ovarian cancer	5.85e-06	8.36e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	5.81e-06	8.3e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SLC5A5—ovarian cancer	5.81e-06	8.3e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	5.78e-06	8.26e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—TYMS—ovarian cancer	5.78e-06	8.26e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SLC5A5—ovarian cancer	5.76e-06	8.23e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CYP1B1—ovarian cancer	5.71e-06	8.15e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APC—ovarian cancer	5.71e-06	8.15e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CG—ovarian cancer	5.69e-06	8.13e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CB—ovarian cancer	5.66e-06	8.09e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CB—ovarian cancer	5.66e-06	8.09e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SLC2A1—ovarian cancer	5.61e-06	8.01e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SLC2A1—ovarian cancer	5.56e-06	7.95e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.44e-06	7.78e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.39e-06	7.71e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CYP1B1—ovarian cancer	5.38e-06	7.68e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.34e-06	7.63e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CYP1B1—ovarian cancer	5.33e-06	7.62e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—TYMS—ovarian cancer	5.3e-06	7.57e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CD—ovarian cancer	5.29e-06	7.56e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CAV1—ovarian cancer	5.25e-06	7.5e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.06e-06	7.23e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CD—ovarian cancer	5.02e-06	7.17e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.01e-06	7.16e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CD—ovarian cancer	5e-06	7.15e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—FASN—ovarian cancer	5e-06	7.15e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CAV1—ovarian cancer	4.94e-06	7.06e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC5A5—ovarian cancer	4.92e-06	7.03e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTEN—ovarian cancer	4.89e-06	6.99e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTEN—ovarian cancer	4.89e-06	6.99e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CG—ovarian cancer	4.78e-06	6.83e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	4.77e-06	6.82e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC2A1—ovarian cancer	4.75e-06	6.79e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—YAP1—ovarian cancer	4.73e-06	6.77e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	4.73e-06	6.76e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.7e-06	6.72e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CAV1—ovarian cancer	4.66e-06	6.65e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.65e-06	6.65e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—TYMS—ovarian cancer	4.61e-06	6.59e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CB—ovarian cancer	4.61e-06	6.59e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CYP1B1—ovarian cancer	4.56e-06	6.51e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CG—ovarian cancer	4.5e-06	6.43e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.45e-06	6.36e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ERBB2—ovarian cancer	4.43e-06	6.33e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ABCB1—ovarian cancer	4.43e-06	6.33e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ABCB1—ovarian cancer	4.39e-06	6.27e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MTOR—ovarian cancer	4.37e-06	6.25e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CB—ovarian cancer	4.37e-06	6.25e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CB—ovarian cancer	4.36e-06	6.23e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—TYMS—ovarian cancer	4.35e-06	6.21e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—TYMS—ovarian cancer	4.31e-06	6.16e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CAV1—ovarian cancer	4.27e-06	6.1e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CG—ovarian cancer	4.24e-06	6.06e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CD—ovarian cancer	4.2e-06	6e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDKN1B—ovarian cancer	4.1e-06	5.86e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.08e-06	5.83e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	4.04e-06	5.77e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.02e-06	5.75e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTEN—ovarian cancer	3.99e-06	5.7e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CD—ovarian cancer	3.95e-06	5.65e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CG—ovarian cancer	3.89e-06	5.56e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CTNNB1—ovarian cancer	3.88e-06	5.54e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—FASN—ovarian cancer	3.86e-06	5.52e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.8e-06	5.43e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PTEN—ovarian cancer	3.78e-06	5.4e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTEN—ovarian cancer	3.77e-06	5.39e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ABCB1—ovarian cancer	3.75e-06	5.36e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CD—ovarian cancer	3.73e-06	5.33e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CAV1—ovarian cancer	3.72e-06	5.31e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—TYMS—ovarian cancer	3.68e-06	5.26e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.67e-06	5.24e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CB—ovarian cancer	3.66e-06	5.23e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.52e-06	5.02e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CAV1—ovarian cancer	3.5e-06	5.01e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CAV1—ovarian cancer	3.47e-06	4.96e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PIK3CA—ovarian cancer	3.45e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PIK3CA—ovarian cancer	3.45e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CB—ovarian cancer	3.45e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.42e-06	4.88e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.39e-06	4.84e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—STAT3—ovarian cancer	3.38e-06	4.83e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NRAS—ovarian cancer	3.37e-06	4.82e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.32e-06	4.74e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CB—ovarian cancer	3.25e-06	4.64e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MAPK3—ovarian cancer	3.23e-06	4.61e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.19e-06	4.56e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.16e-06	4.52e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PTEN—ovarian cancer	3.16e-06	4.52e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MYC—ovarian cancer	3.14e-06	4.49e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.12e-06	4.46e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MAPK1—ovarian cancer	3.07e-06	4.39e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—EGFR—ovarian cancer	3.07e-06	4.39e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.98e-06	4.26e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTEN—ovarian cancer	2.98e-06	4.26e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.98e-06	4.26e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CAV1—ovarian cancer	2.97e-06	4.24e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—ovarian cancer	2.9e-06	4.15e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.89e-06	4.14e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—TYMS—ovarian cancer	2.84e-06	4.06e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.84e-06	4.05e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AKT1—ovarian cancer	2.82e-06	4.03e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AKT1—ovarian cancer	2.82e-06	4.03e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.81e-06	4.02e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTEN—ovarian cancer	2.81e-06	4.01e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CD—ovarian cancer	2.81e-06	4.01e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.78e-06	3.98e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.7e-06	3.86e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PIK3CA—ovarian cancer	2.67e-06	3.81e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PIK3CA—ovarian cancer	2.66e-06	3.8e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.6e-06	3.71e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTEN—ovarian cancer	2.57e-06	3.68e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HRAS—ovarian cancer	2.47e-06	3.52e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.45e-06	3.5e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.42e-06	3.46e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.38e-06	3.4e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—IL6—ovarian cancer	2.36e-06	3.37e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AKT1—ovarian cancer	2.3e-06	3.28e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CAV1—ovarian cancer	2.29e-06	3.27e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTEN—ovarian cancer	2.24e-06	3.21e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PIK3CA—ovarian cancer	2.23e-06	3.19e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—AKT1—ovarian cancer	2.18e-06	3.11e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AKT1—ovarian cancer	2.17e-06	3.1e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTEN—ovarian cancer	2.11e-06	3.02e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.1e-06	3e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTEN—ovarian cancer	2.1e-06	2.99e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.09e-06	2.98e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.07e-06	2.96e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.98e-06	2.83e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.83e-06	2.62e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AKT1—ovarian cancer	1.82e-06	2.61e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.82e-06	2.6e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTEN—ovarian cancer	1.79e-06	2.56e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AKT1—ovarian cancer	1.72e-06	2.45e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AKT1—ovarian cancer	1.62e-06	2.31e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.6e-06	2.29e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.58e-06	2.26e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.49e-06	2.13e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AKT1—ovarian cancer	1.48e-06	2.12e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.48e-06	2.11e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTEN—ovarian cancer	1.38e-06	1.97e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AKT1—ovarian cancer	1.29e-06	1.85e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.26e-06	1.81e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AKT1—ovarian cancer	1.22e-06	1.74e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AKT1—ovarian cancer	1.21e-06	1.73e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AKT1—ovarian cancer	1.03e-06	1.47e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PIK3CA—ovarian cancer	9.75e-07	1.39e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AKT1—ovarian cancer	7.96e-07	1.14e-05	CbGpPWpGaD
